Reactive oxygen species modulate angiotensin II-induced beta-myosin heavy chain gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in neonatal rat cardiomyocytes

Biochemical and Biophysical Research Communications
N L ShihJ J Chen

Abstract

Angiotensin II (Ang II) causes cardiomyocytes hypertrophy. Cardiac beta-myosin heavy chain (beta-MyHC) gene expression can be altered by Ang II. The molecular mechanisms are not completely known. Reactive oxygen species (ROS) are involved in signal transduction pathways of Ang II. However, the role of ROS on Ang II-induced beta-MyHC gene expression remains unclear. Here we found that Ang II increased beta-MyHC promoter activity and it was blocked by Ang II type 1 receptor antagonist losartan. Ang II dose-dependently increased the intracellular ROS. Cardiomyocytes cotransfected with a dominant negative mutant of Ras (RasN17), Raf-1 (Raf301), or a catalytically inactive mutant of extracellular signal regulated kinase (mERK2) inhibited Ang II-induced beta-MyHC promoter activity, indicating Ras/Raf/ERK pathway was involved. Antioxidants such as catalase or N-acetyl-cysteine decreased Ang II-activated ERK phosphorylation and inhibited Ang II-induced beta-MyHC promoter activity. These data indicate that Ang II increases beta-MyHC gene expression in part via the generation of ROS.

References

Mar 31, 1992·Biochemical and Biophysical Research Communications·D L WangC C Liew
Dec 1, 1991·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·K R ChienS Chien
May 16, 1995·Biochemical and Biophysical Research Communications·K G ShyuC C Liew
Jun 6, 1995·Biochemical and Biophysical Research Communications·K G ShyuC C Liew
Mar 30, 1994·Biochemical and Biophysical Research Communications·J G EdwardsE Morkin
Aug 1, 1993·Circulation·S Ballin, C Louis
Dec 15, 1995·Circulation·C Louis, S Ballin
Mar 14, 1997·Science·K IraniP J Goldschmidt-Clermont
Jun 20, 1997·The Journal of Biological Chemistry·A K BhuniaS Chatterjee
Apr 28, 1999·Free Radical Biology & Medicine·S López-OngilD Rodríguez-Puyol
May 18, 1999·Molecular and Cellular Biology·F CharronM Nemer
Jan 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·P ParadisM Nemer

❮ Previous
Next ❯

Citations

Jan 8, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ding AiYi Zhu
Nov 1, 2003·Antioxidants & Redox Signaling·Abdelkarim SabriPamela A Lucchesi
Aug 24, 2005·Antioxidants & Redox Signaling·Haruhiko OhtsuSatoru Eguchi
Sep 22, 2005·Clinical and Experimental Pharmacology & Physiology·Wen-Sen LeePaul Chan
Apr 7, 2005·Current Atherosclerosis Reports·P Christian Schulze, Richard T Lee
Sep 27, 2005·Naunyn-Schmiedeberg's Archives of Pharmacology·Hung-Yu YangTzu-Hurng Cheng
May 6, 2009·Journal of Cellular and Molecular Medicine·Jun CaiHongliang Li
Nov 17, 2006·American Journal of Physiology. Cell Physiology·Victoria C TuQin M Chen
May 8, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Shu-Hui JuanTzu-Hurng Cheng
Jan 29, 2008·Experimental Biology and Medicine·Xiao-Jing ZouShang-Long Yao
May 3, 2015·American Journal of Physiology. Heart and Circulatory Physiology·Elena M V de CavanaghLeón Ferder
Jul 19, 2002·American Journal of Physiology. Heart and Circulatory Physiology·S C LearyC D Moyes
Apr 9, 2015·Journal of Cardiovascular Pharmacology·Francisco Rodrigo Lemos CaldasHeberty di Tarso Fernandes Facundo
Jul 26, 2019·Current Molecular Pharmacology·Aline Maria Brito LucasHeberty Tarso Facundo
Aug 9, 2020·Free Radical Biology & Medicine·Sukanya PhungphongTepmanas Bupha-Intr
May 1, 2021·Biology·Christopher J GilbertFederica Accornero
Aug 11, 2020·Molecular and Cellular Endocrinology·Ana Paula Cremasco TakanoMaria Luiza M Barreto-Chaves
Dec 4, 2003·Journal of the American College of Cardiology·Tzu-Hurng ChengJin-Jer Chen
Jul 9, 2020·Chemical Research in Toxicology·Roman LiJulia Hoeng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.